Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
IGC Pharma (IGC)
NYSE MKT:IGC
Holding IGC?
Track your performance easily
IGC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.27 - $0.91
Previous Close$0.38
Volume737.58K
Average Volume (3M)469.82K
Market Cap
$28.50M
Enterprise Value$27.13M
Total Cash (Recent Filing)$1.55M
Total Debt (Recent Filing)$170.00K
Price to Earnings (P/E)―
Beta0.51
Next Earnings
Feb 12, 2025EPS Estimate
-$0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.19
Shares Outstanding77,449,374
10 Day Avg. Volume438,918
30 Day Avg. Volume469,820
Standard Deviation0.24
R-Squared0.08
Alpha-0.00541
Financial Highlights & Ratios
Price to Book (P/B)3.79
Price to Sales (P/S)24.81
Price to Cash Flow (P/CF)-7.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue18.80
Enterprise Value/Gross Profit37.01
Enterprise Value/Ebitda-3.17
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
IGC Pharma News
Ownership Overview
27.35% Insiders
1.32% Mutual Funds
0.46% Other Institutional Investors
70.06% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
IGC FAQ
What was IGC Pharma’s price range in the past 12 months?
IGC Pharma lowest stock price was $0.27 and its highest was $0.91 in the past 12 months.
What is IGC Pharma’s market cap?
Currently, no data Available
When is IGC Pharma’s upcoming earnings report date?
IGC Pharma’s upcoming earnings report date is Feb 12, 2025 which is in 52 days.
How were IGC Pharma’s earnings last quarter?
IGC Pharma released its earnings results on Nov 14, 2024. The company reported -$0.02 earnings per share for the quarter, beating the consensus estimate of -$0.03 by $0.01.
Is IGC Pharma overvalued?
According to Wall Street analysts IGC Pharma’s price is currently Overvalued.
Does IGC Pharma pay dividends?
IGC Pharma does not currently pay dividends.
What is IGC Pharma’s EPS estimate?
IGC Pharma’s EPS estimate is -$0.03.
How many shares outstanding does IGC Pharma have?
IGC Pharma has 77,449,370 shares outstanding.
What happened to IGC Pharma’s price movement after its last earnings report?
IGC Pharma reported an EPS of -$0.02 in its last earnings report, beating expectations of -$0.03. Following the earnings report the stock price went down -2.703%.
Which hedge fund is a major shareholder of IGC Pharma?
Currently, no hedge funds are holding shares in IGC
---
IGC Pharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth $200.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 4.0%
Last 30 Days ▲ 16.5%
Last 30 Days ▲ 16.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
28.04%
12-Months-Change
Fundamentals
Return on Equity
-117.06%
Trailing 12-Months
Asset Growth
-37.18%
Trailing 12-Months
Company Description
IGC Pharma
India Globalization Capital, Inc. engages in the development and commercialization of cannabinoid based alternative therapies for indications such as Alzheimer's disease, Parkinson's disease, and pain. It operates through the Infrastructure Business and Plant & Cannabinoids Business segments. The Infrastructure Business segment involves the rental of heavy construction equipment, execution of construction contracts, and purchase and reseal of physical commodities used in infrastructure. The Plant & Cannabinoids Business segment comprises the production of plant and cannabinoid-based products, and therapies. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.
---
IGC Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering IGC
1 Year
1 Year Success Rate
2/3 ratings generated profit
1 Year Average Return
+1.27%
reiterated a buy rating 4 months ago
Copying Edward Woo's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +1.27% per trade.
---